Abbott will vote its Mylan shares in favor of Mylan's proposed acquisition of Perrigo June 17, 2015 CenterWatch Staff
Ocular Therapeutix begins enrollment in phase III trial for allergic conjunctivitis June 17, 2015 CenterWatch Staff
Heron Therapeutics initiates phase II trial of HTX-011 for post-operative pain June 17, 2015 CenterWatch Staff
Protalex receives FDA Orphan designation for PRTX-100 to treat immune thrombocytopenia June 17, 2015 CenterWatch Staff
Weill Cornell-N.Y. Presbyterian Hospital to pilot eConsent in oncology clinical trials June 15, 2015 CenterWatch Staff